Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Lymphoid 1

Conditions

Sarcoma, Kaposi 3Epstein-Barr Virus Infections 2Acquired Immunodeficiency Syndrome 2Sarcoma 1Pyloric Stenosis, Hypertrophic 1Nasopharyngeal Carcinoma 1Multi-centric Castleman's Disease 1Lymphoproliferative Disorders 1Immune Reconstitution Inflammatory Syndrome 1Cytomegalovirus Infections 1Castleman Disease 1

Interventions

Valganciclovir 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Nivolumab 2tocilizumab 1pomalidomide 1pembrolizumab 1liposomal doxorubicin 1emvododstat 1efineptakin alfa 1cabozantinib 1Zidovudine 1Sunitinib 1Polymerase Chain Reaction 1Nelfinavir 1Maraviroc 1Lenalidomide 1Ipilimumab 1Immunohistochemistry 1Imatinib Mesylate 1HhAntag691 1Gene Expression Profiling 1Etoposide 1Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Sarcoma, Kaposi × Valganciclovir × Clear all
NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

National Institute of Cancerología

Phase 2 Completed
40 enrolled 6 charts
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
8 enrolled 18 charts
LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

NCT00096538 2015-11-25

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
6 enrolled 6 charts
Sarcoma

Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡